Filtered By:
Management: Hospitals
Countries: Singapore Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 5 results found since Jan 2013.

Paediatric Cerebral Arteriovenous Malformation: Outcomes from a Singapore Children's Hospital
Paediatric brain arteriovenous malformation (bAVM) is a rare and distinct clinical entity. There is a growing body of literature that support the success of multimodality approaches for this difficult condition. The authors aim to firstly, describe our institutional experience with a consecutive series of patients and next, corroborate our results with current literature.
Source: Journal of Stroke and Cerebrovascular Diseases - January 6, 2022 Category: Neurology Authors: Jia Xu Lim, Tien Ming Cheong, Lee Ping Ng, Wan Tew Seow, Felicia Hui Zhuang Chua, Ramez Wadie Kirollos, David Chyi Yeu Low, Sharon Yin Yee Low Source Type: research

Changes in Informed Consent Policy and Treatment Delays in Stroke Thrombolysis
The efficacy of thrombolytic therapy with tissue plasminogen activator (tPA) is highly time dependent. Although clinical guidelines do not recommend written informed consent as it may cause treatment delays, local policy can supersede and require it. From 2014 to 2017, three out of five public hospitals in Singapore changed from written to verbal consent at different time points. We aimed to examine the association of hospital policy changes regarding informed consent on door-to-needle (DTN) times.
Source: Journal of Stroke and Cerebrovascular Diseases - December 19, 2020 Category: Neurology Authors: Hanzhang Xu, Deidre Anne De Silva, Fung Peng Woon, Marcus Eng Hock Ong, David B. Matchar, Janet Prvu Bettger, Daniel T. Laskowitz, Ying Xian Source Type: research

Stroke Care Services in Singapore During COVID-19 Pandemic —A National Perspective
Stroke is a significant cause of admission to Singapore's acute care hospitals. Because of the current COVID-19 pandemic, there have been major changes in the stroke care system. On calling for the public ambulance, those suspected to have COVID-19 infection are taken to the National Center for Infectious Diseases. Otherwise, on arrival at the emergency room, all cases with fever or respiratory symptoms [COVID-19 suspect patients (CSPs)] are evaluated separately by staff wearing full personal protective equipment (PPE). Triage is not delayed. CSPs needing hyperacute therapies are sent to a specially prepared scanner; if no...
Source: Frontiers in Neurology - July 27, 2020 Category: Neurology Source Type: research

20 Developing comprehensive mechanical circulatory support in singapore
Heart transplantation was initiated in Singapore in 1990. Three to six heart transplants are performed annually. The waiting list mortality was about 30%. Hence, mechanical circulatory support was initiated with HeartMate I in 2001. Extracorporeal membrane oxygenation (ECMO) for acute life support became available by 2003. Durable implantable rotary left ventricular assist device (LVAD) with HeartMate IITM (HMII) was introduced in 2007, followed by HeartWareTM HVADTM in 2012 and HeartMate 3TM (HM3) in 2015. 90 consecutive durable implantable devices (58 HMII, 21 HVAD and 11 HM3), were placed from May 2009 to December 2017....
Source: Heart Asia - April 24, 2019 Category: Cardiology Authors: Sivathasan, C. Tags: Keynote Lecture Source Type: research

Boehringer Aims High with Angels Initiative
An innovative scheme to create a community of 1,500 stroke-ready hospitals across Europe has been recognized with the Most Valuable HCP/Healthcare Award at the European arm of theeyeforpharma Awards 2017.The Angel ’s Initiative from Boehringer Ingelheim – which aims to save 100,000 lives by May 2019 – was voted the winner in a unanimous decision by the expert panel of judges.Only one-third of stroke patients in Europe have access to organized stroke care, while just one per cent of stroke patients in emerging markets are provided with lifesaving treatments. In response, the Angels Initiative is working to establish m...
Source: EyeForPharma - April 25, 2017 Category: Pharmaceuticals Authors: Danielle Barron Source Type: news